Get the Stockscreener App
0.189
10.53%
0.018
After Hours:
.18
-0.009
-4.76%
Silexion Therapeutics Corp Stock (SLXN) Forecast
The Silexion Therapeutics Corp (SLXN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $869.70, representing a +460.06K% increase from the current price of $0.189. The highest analyst price target is $1,029.20, and the lowest is $710.20.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SLXN Price Target
Average 1,054.94
(+558.07K% Upside)
Is Silexion Therapeutics Corp (SLXN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.12 | Neutral |
| STOCH(9,6) | 8.6304 | Buy |
| STOCHRSI(14) | 35.32 | Neutral |
| MACD(12,26) | -0.0993 | Buy |
| ADX(14) | 18.58 | Neutral |
| William %R | -89.03 | Buy |
| CCI(14) | -57.03 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2206
Sell
|
0.217
Sell
|
| MA20 |
0.2767
Sell
|
0.273
Sell
|
| MA50 |
0.4327
Sell
|
0.7565
Sell
|
| MA100 |
1.718
Sell
|
3.0832
Sell
|
| MA200 |
7.8061
Sell
|
14.46
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SLXN could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on SLXN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.12 indicates that SLXN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 8.6304 indicates that SLXN is oversold. This indicates that SLXN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 35.32 indicates that SLXN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.58 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -57.03 indicates that SLXN is still oversold but not to an extreme extent.
Long-term SLXN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Silexion Therapeutics Corp financial reports and earnings history, Silexion Therapeutics Corp (SLXN) stock could reach $2,418.85 by 2030, $6,432.48 by 2040 and $8,803.75 by 2050. See the projected annual prices until 2050 of the Silexion Therapeutics Corp stock below:
- Silexion Therapeutics Corp (SLXN) is expected to reach an average price of $4,434.62 in 2035, with a high prediction of $4,651.32 and a low estimate of $4,439.27. This indicates an $2.35M% rise from the last recorded price of $0.189.
- Silexion Therapeutics Corp (SLXN) stock is projected to chart a bullish course in 2040, with an average price target of $6,132.62, representing an $3.24M% surge from its current level. The forecast ranges from a conservative $6,133.92 to a sky-high $6,432.48.
- Our analysts predict Silexion Therapeutics Corp (SLXN) to jump 3.92M% by 2045, soaring from $7,401.67 to an average price of $7,400.17, potentially reaching $7,837.48. While $7,401.67 is the low estimate, the potential upside is significant.
- Silexion Therapeutics Corp (SLXN) stock is expected to climb by 2050, reaching an average of $8,215.33, a $4.35M% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8,803.75 and $8,216.83, respectively, highlighting the market's uncertainty.
Silexion Therapeutics Corp Stock (SLXN) Year by Year Forecast
Silexion Therapeutics Corp Stock (SLXN) Price Forecast for 2026
The predicted value for Silexion Therapeutics Corp (SLXN) in 2026 is set at an average of $783.17. Estimates vary from a peak of $1,566.17 to a trough of $0.163, indicating an +414.27K% surge from the present price of $0.189.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1,104.40 | $710.20 | $1,029.20 | +584.24K% |
| December, 2026 | $1,339.43 | $1,184.72 | $1,214.96 | +708.59K% |
Silexion Therapeutics Corp Stock (SLXN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Silexion Therapeutics Corp (SLXN) is $1,159.45, with a high forecast of $1,399.69 and a low forecast of $919.21. This indicates an +613.37K% increase from the last price of $0.189.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1,406.72 | $1,360.49 | $1,330.65 | +744.20K% |
| February, 2027 | $1,105.59 | $1,272.08 | $1,191.33 | +584.87K% |
| March, 2027 | $1,267.66 | $1,281.15 | $1,249.65 | +670.62K% |
| April, 2027 | $1,309.72 | $1,318.72 | $1,399.69 | +692.87K% |
| May, 2027 | $1,227.29 | $1,243.79 | $1,290.35 | +649.26K% |
| June, 2027 | $1,234.45 | $1,224.04 | $1,213.82 | +653.05K% |
| July, 2027 | $1,156.19 | $1,174.73 | $1,210.51 | +611.64K% |
| August, 2027 | $1,072.98 | $1,101.45 | $1,129.92 | +567.62K% |
| September, 2027 | $1,049.19 | $1,055.64 | $1,065.53 | +555.03K% |
| October, 2027 | $984.91 | $1,007.43 | $1,031.07 | +521.02K% |
| November, 2027 | $961.77 | $963.07 | $961.92 | +508.77K% |
| December, 2027 | $933.53 | $919.21 | $944.38 | +493.83K% |
Silexion Therapeutics Corp Stock (SLXN) Price Forecast for 2028
In 2028, Silexion Therapeutics Corp (SLXN) is projected to reach an average price of $555.83, with a high projection of $918.34 and a low estimate of $193.32. This indicates an +293.99K% rise from the last price of $0.189.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $860.55 | $861.60 | $918.34 | +455.22K% |
| February, 2028 | $811.46 | $812.76 | $844.92 | +429.24K% |
| March, 2028 | $749.22 | $755.02 | $794.07 | +396.31K% |
| April, 2028 | $700.27 | $702.98 | $733.13 | +370.42K% |
| May, 2028 | $626.25 | $626.55 | $684.99 | +331.25K% |
| June, 2028 | $567.36 | $570.41 | $610.76 | +300.09K% |
| July, 2028 | $496.88 | $498.46 | $551.52 | +262.80K% |
| August, 2028 | $441.91 | $442.31 | $481.49 | +233.71K% |
| September, 2028 | $386.90 | $387.48 | $426.92 | +204.61K% |
| October, 2028 | $312.14 | $312.54 | $368.15 | +165.05K% |
| November, 2028 | $252.33 | $252.42 | $296.99 | +133.41K% |
| December, 2028 | $193.11 | $193.32 | $237.16 | +102.08K% |
Silexion Therapeutics Corp Stock (SLXN) Price Forecast for 2029
The 2029 price forecast for Silexion Therapeutics Corp Stock (SLXN) is $1,536.94 on average, with a high prediction of $3,058.88 and a low estimate of $14.99. This represents an +813.09K% increase from the previous price of $0.189.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $119.70 | $119.70 | $178.15 | +63,235% |
| February, 2029 | $59.84 | $59.87 | $104.58 | +31,559% |
| March, 2029 | $1,903.16 | $14.99 | $337.16 | +1.01M% |
| April, 2029 | $2,873.67 | $1,987.94 | $2,441.80 | +1.52M% |
| May, 2029 | $3,038.77 | $2,925.10 | $2,983.42 | +1.61M% |
| June, 2029 | $3,062.80 | $3,098.98 | $3,058.88 | +1.62M% |
| July, 2029 | $2,739.18 | $2,907.18 | $3,020.94 | +1.45M% |
| August, 2029 | $2,824.80 | $2,854.80 | $2,827.78 | +1.49M% |
| September, 2029 | $2,742.41 | $2,847.33 | $2,928.38 | +1.45M% |
| October, 2029 | $2,678.06 | $2,727.56 | $2,759.10 | +1.42M% |
| November, 2029 | $2,592.67 | $2,602.87 | $2,637.44 | +1.37M% |
| December, 2029 | $2,460.10 | $2,478.64 | $2,561.95 | +1.30M% |
Silexion Therapeutics Corp Stock (SLXN) Price Forecast for 2030
Silexion Therapeutics Corp Stock (SLXN) is expected to reach an average price of $1,728.74 in 2030, with a high forecast of $2,418.85 and a low forecast of $1,038.63. This signifies an +914.58K% surge from the last price of $0.189.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2,331.93 | $2,357.43 | $2,418.85 | +1.23M% |
| February, 2030 | $2,245.80 | $2,251.05 | $2,297.46 | +1.19M% |
| March, 2030 | $2,129.65 | $2,131.51 | $2,212.83 | +1.13M% |
| April, 2030 | $2,016.01 | $2,027.41 | $2,081.10 | +1.07M% |
| May, 2030 | $1,906.93 | $1,908.43 | $1,985.44 | +1.01M% |
| June, 2030 | $1,824.54 | $1,826.04 | $1,877.59 | +965.27K% |
| July, 2030 | $1,675.55 | $1,675.69 | $1,785.97 | +886.43K% |
| August, 2030 | $1,560.50 | $1,567.50 | $1,645.22 | +825.56K% |
| September, 2030 | $1,419.75 | $1,422.45 | $1,526.45 | +751.09K% |
| October, 2030 | $1,297.37 | $1,298.77 | $1,389.48 | +686.34K% |
| November, 2030 | $1,183.58 | $1,183.97 | $1,267.09 | +626.13K% |
| December, 2030 | $1,037.13 | $1,038.63 | $1,151.71 | +548.64K% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):